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Abstract
Background
Dopamine D2/D3 receptor availability in the striatum has been linked with executive function
in healthy individuals, and is below control levels among drug addicts, possibly contributing
to diminished executive function in the latter group. This study tested for an association of
striatal D2/D3 receptor availability with a measure of executive function among research par-
ticipants who met DSM-IV criteria for methamphetamine dependence.
Methods
Methamphetamine users and non-user controls (n = 18 per group) completed the Wisconsin
Card Sorting Test and positron emission tomography with [18F]fallypride.
Results
The methamphetamine users displayed significantly lower striatal D2/D3 receptor availabil-
ity on average than controls after controlling for age and education (p = 0.008), but they did
not register greater proportions of either perseverative or non-perseverative errors when
controlling for education (both ps 0.622). The proportion of non-perseverative, but not
perseverative, errors was negatively correlated with striatal D2/D3 receptor availability
among controls (r = -0.588, p = 0.010), but not methamphetamine users (r = 0.281, p =
0.258), and the group-wise interaction was significant (p = 0.030).
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Conclusions
These results suggest that cognitive flexibility, as measured by perseverative errors on the
Wisconsin Card Sorting Test, is not determined by signaling through striatal D2/D3 receptors
in healthy controls, and that in stimulant abusers, who have lower D2/D3 receptor availabil-
ity, compensation can effectively maintain other executive functions, which are associated
with D2/D3 receptor signaling in controls.
Introduction
Drug addiction is a complex disorder that often is associated with inflexible behavior and defi-
cient executive function [1]. Numerous studies have demonstrated poorer performance on
tasks that assess executive function among individuals with a history of chronic drug abuse rel-
ative to healthy controls [2–14]. Problems with executive function, including cognitive inflexi-
bility, difficulty focusing attention, and diminished self-control, have been implicated in the
etiology of compulsive drug use, and reduced function in these domains has been viewed as a
substantial impediment to successful treatment (for reviews, see [1, 15, 16]). As such, research
aimed at elucidating the neural underpinnings of the relatively less effective executive function
among some substance-dependent individuals compared to non-user controls may lead to new
therapeutic interventions.
Executive function is primarily subserved by the prefrontal cortex, which exerts “top-down”
control over subcortical structures, such as the striatum and amygdala, which are responsive to
“bottom-up” sensory input [17]. Despite being principally ascribed to the prefrontal cortex
[17–19], however, the processes of decision-making and selection of actions are mediated by
subcortical structures as well. In particular, D2/D3 receptor availability in the striatum has been
found to be correlated positively with performance on laboratory tests that rely heavily on exec-
utive processes in healthy individuals [20–25], and in carriers of the Huntington’s disease
mutation [26]. This is particularly relevant to addictive disorders because striatal D2/D3 recep-
tor availability is typically lower among drug addicts than non-user controls (for a review, see
[27]). As such, it stands to reason that low striatal D2/D3 receptor availability may be linked
with poor performance on laboratory tests of executive function among individuals with sub-
stance-use disorders. Yet, to our knowledge, no studies have examined whether the relation-
ships between striatal D2/D3 receptor availability and executive functions seen in healthy
individuals extend to substance abusers, who have relatively low striatal D2/D3 receptor
availability.
In this study, striatal D2/D3 receptor availability was examined in relation to performance
on the Wisconsin Card Sorting Test (WCST), a laboratory measure of executive function.
Research participants who met DSM-IV criteria for methamphetamine (MA) dependence
were compared with a group of healthy controls. MA-dependent individuals were selected as a
group for study because case-control studies find that they display low striatal D2/D3 receptor
availability (for a review, see [28]) and poorer performance on the WCST than healthy controls
([2, 3]; although several studies have not observed similar performance differences among
cocaine users, e.g. [4–6, 12, 29, 30]). On the basis of the literature cited above, we expected that
MA users would exhibit lower striatal D2/D3 receptor availability and worse performance on
the WCST. We hypothesized that striatal D2/D3 receptor availability would be negatively corre-
lated with errors on the WCST among both MA users and non-users. Further, we hypothesized
that WCST performance measures would be more strongly related to striatal BPND in MA
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users than in controls, in line with our previous finding regarding the relationship between
striatal BPND and temporal discounting, another measure of executive function [31].
Methods
Participants
Procedures were approved by the University of California Los Angeles (UCLA) Office for Pro-
tection of Research Subjects. Participants were recruited using Internet and local newspaper
advertisements. All provided written informed consent and underwent eligibility screening
using questionnaires, the Structured Clinical Interview for DSM-IV (SCID) [32], and a physical
examination. Eighteen individuals who met criteria for current MA dependence, but were not
seeking treatment for their addiction, and 18 controls, completed the study. D2/D3 receptor-
availability data from all but two of the MA users and all of the controls have been reported
previously [31], and smaller subsets were included in other studies from our laboratory regard-
ing striatal D2/D3 receptor availability [33–37].
The exclusion criteria were: CNS, cardiovascular, pulmonary, hepatic, or systemic disease;
HIV seropositive status; pregnancy; lack of English fluency; MRI ineligibility (e.g. metal
implants, claustrophobia); current use of psychotropic medications; current Axis I disorder
including substance abuse or dependence for any substance other than nicotine (all MA users
met criteria for MA dependence; substance-induced mood disorders were also not exclusionary
for this group).
A diagnosis of MA dependence and a positive urine test for MAmetabolites at intake were
required for MA-group participants, who completed the study as inpatients at the UCLA Gen-
eral Clinical Research Center, and were prohibited from using any drugs (besides nicotine in
cigarettes and caffeine in beverages) for 4–7 days before testing. Most MA users completed the
behavioral and imaging measures 2 days apart (ns = 16 within 1 week, one 11 days apart, and
one 415 days apart). Controls were studied on a nonresidential basis, and most completed the
measures within a few days or weeks (ns = seven within 1 week, nine 1–6 weeks apart, one 337
days apart, and one 488 days apart). Relationships between imaging and behavioral variables
did not depend on the lag between measures, and excluding the individuals with long lags did
not substantially change the results. Each participant was required to provide a urine sample
on each test day that was negative for amphetamine, cocaine, MA, benzodiazepine, opiate, and
cannabinoid metabolites. Compensation was provided in the form of cash, gift certificates, and
vouchers.
Executive function
Executive function was assessed with the Wisconsin Card Sorting Test (WCST) [38]. While
performing this non-computerized version of the test, the participant is presented with four
sample cards, each depicting between one and four geometric shapes (triangle, star, cross, or
circle), all of the same color (red, green, yellow, or blue). He or she is instructed to select a new
card on which the items are of a different number, shape, and/or color, and then to match the
drawn card to one of the sample cards using one of the attributes, without knowing the pre-
defined matching criterion. The participant is informed after each response whether he/she
was correct or incorrect. Subsequently, a new card is drawn, and the task proceeds. Once 10
consecutive correct matches are made, the criterion for success is switched (e.g., where match-
ing by color first yields success, the matching criterion is switched to geometric shape, etc.).
The task is untimed, and terminates when the participant reaches six correct categories or
cycles through all 128 cards. The WCST is widely used as a test of executive function, and stud-
ies have shown that individuals with a history of MA abuse often perform more poorly on this
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task than non-user controls (e.g. users tend to register more errors) [2, 3]. In this study, main
outcome measures of interest included the proportion of trials registered as perseverative errors
(i.e., continuing to match on an attribute that was previously identified as incorrect within a
given matching rule) and the proportion of trials registered as non-perseverative errors (i.e.,
incorrectly matching in a manner not previously established as incorrect). Although the num-
ber of correct categories can be tallied (number of times a set of 10 cards were correct in a row
for the same attribute), we did not examine this variable in relation to receptor availability
because only three participants (all MA users) achieved less than the maximum six categories
possible.
D2/D3 receptor availability
Dopamine D2/D3 receptor availability was assessed using a Siemens EXACT HR+ PET scanner
in 3D mode with [18F]fallypride as the radioligand [39]. Following a 7-min transmission scan
acquired using a rotating 68Ge/68Ga rod source to measure and correct for attenuation, PET
dynamic data acquisition was initiated with a bolus injection of [18F]fallypride (~5 mCi ± 5%,
specific activity 1 Ci/μmol). Emission data were acquired in two 80-min blocks, separated by
a 10-20-min break.
Raw PET data were corrected for decay, attenuation, and scatter, and then reconstructed
using ordered-subsets expectation-maximization (OSEM) (3 iterations; 16 subsets), using
ECAT v7.2 software (CTI PET Systems Inc., Knoxville, TN). Reconstructed data were com-
bined into 16 images (each representing an average of 10 min of dynamic data), and the images
were motion-corrected using FSL McFLIRT [40], and co-registered to the individual’s struc-
tural MRI scan image using a six-parameter, rigid-body transformation computed with the
ART software package [41]. Structural images were magnetization-prepared, rapid-acquisition,
gradient-echo (MPRAGE) scans, acquired during a separate session using a Siemens Sonata
1.5T MRI scanner. All images were registered to MNI152 space using FSL FLIRT [42]. The pri-
mary volume of interest (VOI) was the striatum, and exploratory analyses were carried out in
other subcortical and cortical VOIs with appreciable [18F]fallypride BPND (i.e., globus pallidus,
amygdala, thalamus, midbrain, insula, hippocampus, anterior cingulate cortex, and medial and
lateral orbitofrontal cortices) in order to explore the specificity of potential relationships
observed in the striatum. Volumes of interest (VOIs) were derived from the Harvard-Oxford
atlases transformed into individual native space, or defined using FSL FIRST [41]. For VOI
analysis, the striatum was divided into three functional subdivisions as described previously
[43]: the limbic striatum consisted of the ventral striatum; the associative striatum consisted of
the precommissural dorsal putamen, precommissural dorsal caudate, and postcommissural
caudate; and the sensorimotor striatum consisted of the postcommissural putamen [44].
Time-activity data within VOIs were imported into the PMOD 3.2 kinetic modeling analysis
program (PKIN; PMOD Technologies Ltd., Zurich, Switzerland), and time-activity curves
were fit using the Simplified Reference Tissue Model 2, SRTM2 [45]. The cerebellum (exclud-
ing the vermis) was used as the reference region [46]. The rate parameter for transfer of the
tracer from the reference region to plasma (k20) was computed as the volume-weighted average
of estimates from fits to receptor-rich regions (caudate and putamen) calculated using the sim-
plified reference tissue model (SRTM) [47], as suggested by Ichise et al. [48]. Time-activity
curves were re-fit using SRTM2 [45], with the computed k20 value applied to fits to all brain
regions. Regional binding potential referred to non-displaceable binding and was calculated as
BPND = R1(k20 / k2a - 1), where R1 = K1 / K10 is the ratio of tracer-delivery parameters for the tis-
sue of interest and reference tissue, k20 is the rate parameter for the transfer of tracer from the
reference tissue to the plasma, and k2a is the effective rate parameter for transfer of tracer from
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the tissue of interest to the plasma [49–51]. Volume-weighted bilateral averages of all VOIs
were used for analyses.
Statistical analyses
Statistical analyses were carried out using SPSS v23 (IBM Corp., Armonk, NY). Continuous
variables were assessed for homogeneity of variance across groups using Levene’s tests. Demo-
graphic variables were examined for group differences using two-tailed independent samples t-
tests, Mann-Whitney U-tests, or Fisher’s exact tests, as appropriate. Group differences in exec-
utive function measures and BPND were tested using separate independent-samples t-tests, and
ANOVA was used to confirm group differences when controlling for confounding demo-
graphic variables; covariates were identified using forward regression predicting the dependent
measure of interest. Linear regressions were used to test potential relationships between puta-
tive predictor variables and outcome measures of interest, with potential confounding demo-
graphic variables included as covariates. Potential group differences in the strength of the
relationships between BPND and WCST measures were assessed using linear regression, with a
group x BPND interaction term entered in the model along with group and BPND; interactions
with covariates were not included in the model. The threshold for statistical significance was
set at α = 0.05 for all analyses.
Results
The groups included similar proportions of males and females (p = 1.00; Table 1), as well as
tobacco smokers and non-smokers (p = 0.471), and did not differ in age (p = 0.258) or ethnic
group composition (p = 0.572); however, MA users reported significantly fewer years of formal
education than controls on average (p = 0.010).
Table 1. Characteristics of research participants.
Group Controls (n = 18) MA users (n = 18)
Sex (M/F) 11/7 10/8
Age (years) 36.4 ± 9.2 (19–
51)
33.1 ± 7.8 (19–46)
Education (years) 14.3 ± 2.2 (10–
18)
12.6 ± 1.5 (11–16)
*
Ethnicity (White/Hispanic or Latino/Asian/Native American/
Other†)
11/4/2/1/0 11/4/2/0/1
No. daily tobacco smokers (M/F) 7/4 9/5
Cigarettes per day (daily smokers only) 12.8 ± 4.9 (8–20) 12.1 ± 11.7 (3–40)
Years smoking (daily smokers only) 17.5 ± 11.4 (3–
35)
17.3 ± 9.6 (3–34)
FTND score (daily smokers only) 3.5 ± 2.3 (0–8) 3.1 ± 2.8 (0–9)
Duration of regular MA use (years) N/A 9.3 ± 7.9 (0.5–24)
Frequency of MA use (days in last 30 days) N/A 21.9 ± 8.7 (5–30)
Intensity of MA use (grams in last week) N/A 2.8 ± 3.3 (0.3–
14.5)
Data are presented as mean + SD (range), except for sex, ethnicity, and smoking status.
†Other refers to individuals not identifying as White, African American, Hispanic/Latino, Asian, or Native
American
FTND: Fagerström Test for Nicotine Dependence (possible range: 0 [low]—10 [high]; [52])
*Significant group difference, p < .05.
doi:10.1371/journal.pone.0143510.t001
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As shown in Table 2, striatal BPND was lower among MA users than controls, and this
group difference was statistically significant when controlling for both age and years of formal
education; age and education were respectively selected first and second (while sex and smok-
ing status were excluded) by a forward step-wise regression predicting striatal BPND with
demographic variables (correlation between striatal BPND and age: r = -0.637, p< 0.0005; cor-
relation between striatal BPND and education: r = 0.418, p = 0.011; S1 and S2 Tables), consistent
with previous reports [53, 54].
Compared to controls, MA users tended to register greater proportions of both non-persev-
erative errors and perseverative errors, but there was no evidence of group differences in the
proportions of errors when controlling for years of formal education; education was selected as
the sole predictor (while age, sex, years of education, and smoking status were excluded) by a
forward step-wise regression predicting WCST proportion of non-perseverative errors with
demographic variables (correlation between the proportion of non-perseverative errors and
education: r = -0.435, p = 0.008; S1 and S3 Tables).
Multiple regression analyses indicated that the relationship between the proportion of non-
perseverative errors and striatal BPND differed significantly between MA users and controls, as
evidenced by the significant effect of a group x BPND product term, which was calculated to
represent the interaction effect and entered into the model along with group and BPND (R
2 =
0.13, F1,32 = 5.13, p = 0.030). Analogous post-hoc analyses indicated that the group by striatal
BPND interaction was apparent in the associative subdivision of the striatum (group x BPND: R
2
= 0.22, F1,32 = 5.39, p = 0.027, with apparently smaller effects in limbic [group x limbic striatum
BPND: p = 0.143] and sensorimotor divisions of the striatum [group x sensorimotor striatum
BPND: p = 0.078]), but this effect was not significant following correction for multiple compari-
sons using the Holm-Bonferroni method.
A forward step-wise regression selected striatal BPND (while excluding age, sex, education,
and smoker status) as the best and sole predictor of the proportion of non-perseverative errors
among controls, accounting for 35% of the variance across this group (F1,16 = 8.45, p = 0.010).
The correlation coefficient for the relationship between the proportion of non-perseverative
errors and striatal BPND among controls was r = -0.588 (MA users: r = 0.281, p = 0.258; Fig 1).
Analogous post-hoc analyses revealed significant negative correlations between the proportion
of non-perseverative errors and BPND in all three striatal functional subdivisions among con-
trols (limbic striatum: r = -0.520, p = 0.027; associative striatum: r = -0.608, p = 0.007; sensori-
motor striatum: r = -0.564, p = 0.015; Fig 2), and these survived correction for multiple
comparisons using the Holm-Bonferroni method. An analogous forward step-wise regression
in MA users did not select any of the independent variables (i.e., striatal BPND, age, sex, educa-
tion, smoker status) as significant predictors of the proportion of non-perseverative errors in
that group.
With respect to perseverative errors, there was no evidence of a group by striatal BPND inter-
action (p = 0.183), and the proportion of perseverative errors was not significantly correlated
with striatal BPND in either group, (both p 0.318; Fig 1). Although the proportions of persev-
erative and non-perseverative errors were positively correlated in both groups (controls:
r = 0.519, p = 0.027; MA users: r = 0.646, p = 0.004), a post hoc Steiger’s z-test indicated that,
among controls only, striatal BPND was significantly more strongly correlated with the propor-
tion of non-perseverative than perseverative errors (z = -1.79, one-tailed p = 0.037).
Discussion
The goal of this study was to test the hypotheses that striatal D2/D3 receptor availability would
be linked with executive function, as measured by the WCST, with greater receptor availability
D2/D3 Receptor Availability and Executive Function
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accompanying better performance; and that this association would be stronger in MA-depen-
dent participants than in healthy controls. This hypothesis was based mainly on reports that
striatal D2/D3 receptor availability is positively associated with performance on laboratory tests
of executive function among healthy individuals who do not use drugs of abuse [20–25], and is
typically lower among drug addicts than non-user controls (for a review, see [27]). We rea-
soned that the linear relationship found among non-users would extend to, and potentially
would be stronger among MA-users, in a manner analogous to the greater dependence on D2/
D3 receptor availability of performance on a delay discounting task in MA-dependent than in
control subjects [31]. In contrast to our hypothesis and to previous reports [2, 3], we found
that MA users did not register greater proportions of errors in this study, when controlling for
education, despite displaying significantly lower striatal D2/D3 receptor availability on average
than controls, after controlling for age and education. Furthermore, striatal D2/D3 receptor
availability was negatively correlated with the proportion of non-perseverative errors, but not
perseverative errors among controls but not MA users.
The present study is one of the first to examine a discrete measure of executive function in
relation to D2/D3 receptor availability in individuals with a substance-use disorder [55];
although a small number have utilized alternate neurochemical measures of striatal dopami-
nergic neurotransmission [56, 57]. Thus, it addresses an important gap in the literature because
executive deficits, particularly involving cognitive flexibility and sensitivity to negative feed-
back, have been implicated in the etiology of compulsive drug use, and are viewed as substan-
tial obstacles to treatment (for reviews, see [1, 15, 16]). Our results suggest that, although
certain aspects of cognitive function, indexed by non-perseverative errors on the WCST, may
be related to striatal D2/D3 receptor availability in individuals who do not abuse drugs, low
striatal D2/D3 receptor availability does not appear to influence one measure of executive func-
tion, specifically cognitive inflexibility, as measured by perseverative errors among MA users.
This finding is surprising in light of findings that acute administration of a D2 receptor antago-
nist [58] as well as administration of MA according to a subchronic regimen that reduces stria-
tal neurochemical markers of dopaminergic neurotransmission [59] impair cognitive flexibility
in monkeys. The present finding in humans is intriguing because it raises the possibility that
compensatory neural mechanisms serve to buffer at least some aspects of executive function
from the potentially detrimental effects of low striatal D2/D3 receptor availability in stimulant
abusers.
Table 2. Comparison of striatal BPND andWCST performance between MA users and controls (n = 18 each).
Measure Means (SEM) Independent samples
t-test
ANOVA with covariates
MA users Controls t (df) p F (df) p ηp2
Whole striatum BPND 17.56 (0.64) 19.85 (0.93) 2.03 (34) 0.050 9.49 (1,32) 0.004 0.229
LST BPND 15.53 (0.54) 17.45 (0.73) 2.12 (34) 0.042 10.26 (1,32) 0.003 0.243
AST BPND 17.41 (0.64) 19.45 (0.95) 1.78 (34) 0.085 7.11 (1,32) 0.012 0.182
SMST BPND 19.44 (0.69) 21.76 (1.06) 1.84 (34) 0.075 9.14 (1,32) 0.005 0.222
WCST proportion of
NPEs 0.10 (0.02) 0.08 (0.01) 1.61 (34) 0.117 0.34 (1,33) 0.566 0.010
PEs 0.12 (0.02) 0.09 (0.01) 1.36 (34) 0.184 0.29 (1,33) 0.592 0.009
ANOVA covariates are age and years of formal education for BPND analyses, and age for WCST analyses
LST: limbic striatum; AST: associative striatum; SMST: sensorimotor striatum;
NPEs: non-perseverative errors; PEs: perseverative errors.
doi:10.1371/journal.pone.0143510.t002
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That striatal D2/D3 receptor availability was negatively correlated with the proportion of
non-perseverative, but not perseverative, errors among healthy controls is broadly consistent
with a report that dorsal striatal D2/D3 receptor availability is positively associated with sensi-
tivity to positive feedback (i.e., the tendency to follow positive feedback with a correct response)
but not to negative feedback (i.e., the ability to change matching criteria following negative
feedback) in healthy monkeys during reversal learning [60]. An important distinction, how-
ever, is that although a high proportion of perseverative errors in the WCST essentially reflects
insensitivity to negative feedback (the tendency to persist with a matching criterion that the
subject has already been informed is incorrect), the proportion of non-perseverative errors is
not a pure measure of insensitivity to positive feedback—i.e., it could reflect imprecise learning
of the matching criterion, or deficits in working memory, attention, and other cognitive pro-
cesses. Although the number of perseverative errors on the WCST essentially reflects insensi-
tivity to negative feedback, it may not constitute a direct measure of negative reinforcement
Fig 1. Relationships between striatal D2/D3 receptor availability and executive function measures. Regression lines illustrate correlations between
striatal dopamine D2/D3 receptor availability (indexed by [
18F]fallypride BPND) and proportions of trials registered as non-perseverative (top row) and
perseverative (bottom row) errors in methamphetamine (MA) users and non-user controls. Pearson product-moment correlation coefficients are shown (r
values).
doi:10.1371/journal.pone.0143510.g001
D2/D3 Receptor Availability and Executive Function
PLOS ONE | DOI:10.1371/journal.pone.0143510 December 14, 2015 8 / 16
learning in the context of the larger task, which requires greater executive control than simpler
reinforcement learning tasks. Indeed, in contrast to a recent PET study in humans, which
found an inverted U-shaped relationship between striatal D2/D3 receptor availability and a
more pure measure of learning from negative feedback [61], the present study found no such
relationship between striatal D2/D3 receptor availability and the proportion of perseverative
errors on the WCST, either in the combined sample (p = 0.567), or in controls (p = 0.733) or
MA users (p = 0.502), separately.
Still, current computational theories hypothesize that learning from negative feedback is
mediated, in part, by D2 receptor-containing striatal medium spiny neurons in the indirect (or
‘no-go’) pathway [62], and that reductions in striatal D2/D3 receptor levels, which may occur
following chronic methamphetamine abuse [59], would serve to erode dopaminergic control
over the ‘no-go’ system, thus diminishing the capacity to learn from negative feedback. Also in
line with a function of D2/D3 receptor signaling in learning form negative feedback is the obser-
vation that carriers of the A1 allele of the ANKK1-Taq1A polymorphism exhibit subtle perfor-
mance deficits in reversal learning as compared to homozygotes without this allele [63] and
show reduced interaction between the posterior medial frontal cortex and the hippocampus—
referred to as the performance monitoring network—in response to negative feedback than
those without the A1 allele [64]. As well, results from a study involving a small sample of absti-
nent cocaine abusers and non-user controls who performed the color-word Stroop task, which
measures executive function and is heavily dependent on cognitive flexibility, provide prelimi-
nary evidence that lower striatal D2/D3 receptor availability is linked to blunted neural
responses (e.g., midbrain activation) during error processing among stimulant abusers [55].
Fig 2. Relationships between D2/D3 receptor availability in striatal subregions and executive function measures. Regression lines illustrate
correlations between striatal dopamine D2/D3 receptor availability (indexed by [
18F]fallypride BPND) and proportions of trials registered as non-perseverative
and perseverative errors in the striatal functional subdivisions of methamphetamine (MA) users (bottom row) and non-user controls (top row). Pearson
product-moment correlation coefficients are shown (r values).
doi:10.1371/journal.pone.0143510.g002
D2/D3 Receptor Availability and Executive Function
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Contrary to this reasoning, MA users did not register greater proportions of perseverative
errors than controls, despite having lower striatal D2/D3 receptor availability on average. How-
ever, it has also been reasoned that under conditions of low tonic dopaminergic transmission,
which is hypothesized to coincide with reduced striatal D2/D3 receptor density following
chronic stimulant abuse [27], the capacity to learn from negative feedback is enhanced [61, 62],
which could help to buffer MA users from the potentially detrimental effects of low striatal D2/
D3 receptor density on learning from negative feedback.
In the single other study that examined striatal D2/D3 receptor availability in relation to
WCST performance, the total number of errors, a raw measure that does not take into account
the type of error or total number of trials, was negatively correlated with D2/D3 receptor avail-
ability in both striatal regions tested (caudate and putamen) of healthy control subjects [20]; a
similar trend was found in controls studied here (r = -0.405, p = 0.091).
That MA users did not register significantly greater proportions of perseverative or non-
perseverative errors than controls is consistent with two previous studies [56, 65]. Two others
found significant group differences with both perseverative and non-perseverative errors on
the WCST: one with MA users abstinent longer than one month [3]; the other with MA users
abstinent on average longer than two years [2]. Potential reasons for this discrepancy between
the results of these latter two studies and the lack of a difference in performance compared
with controls in the present study are not immediately clear, but may reflect a variety of differ-
ences in the samples studied. For example, in one of the two prior studies that found a group
difference in WCST performance, all of the MA users (N = 32) self-administered the drug by
the intravenous route and were Asian, and HIV seropositive status was not excluded [2], unlike
the characteristics of the sample studied here. In the other study that found differences in
WCST performance in a sample of abstinent MA users, all MA users (N = 43) were hospital-
ized treatment-seeking patients [3], also unlike the participants in the present study. Certainly,
the larger sample sizes in those studies provided more power than those of the present study to
detect group differences; however given the exceedingly marginal group difference in WCST
performance seen here after controlling for education, it seems unlikely that using similar-
sized samples in this study would have returned a significant group difference in WCST perfor-
mance. Indeed, several studies have also found no significant difference on measures of WCST
errors between controls and other populations of drug abusers [9, 66], who also typically dis-
play low striatal D2/D3 receptor availability (for a review, see [27]), including stimulant users
[4–6, 12, 29, 30].
That WCST error rates can be similar between controls and MA users despite the latter
group displaying lower striatal D2/D3 receptor availability, coupled with the finding that the
non-perseverative error rate is correlated with striatal D2/D3 receptor availability in controls
but not MA users, suggests that striatal D2/D3 receptor availability contributes to certain
aspects of executive function in healthy individuals, but that these associations become uncou-
pled in MA dependence. As such, executive function may be primarily subserved by non-D2/
D3 mechanisms in chronic stimulant abusers who have low striatal D2/D3 receptor availability.
Broadly in line with this view is the observation that a deficit in reversal learning in monkeys,
induced by an escalating dose regimen of MA that produced persistent reductions in striatal
D2/D3 receptor availability, was transient whereas the neurochemical loss was long-term [59].
It is important to note that both WCST performance measures and D2/D3 receptor avail-
ability were significantly correlated with years of formal education in our sample. This collin-
earity in predictive variables is an important limitation because it makes it difficult to
disentangle the influence of education on the relationship between WCST performance and
striatal D2/D3 receptor availability. Despite the established relationship between cognition and
education, studies of cognition in MA users do not consistently control for education [67].
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Studies testing the association of D2/D3 receptor availability with cognition have also not con-
sistently considered the potential confounding effect of education [21, 24–26]. Still, considering
the maladaptive behavioral patterns associated with low striatal D2/D3 receptor availability (for
a review, see [27]), it seems reasonable to expect that low striatal D2/D3 receptor availability
may contribute to less educational attainment. Another possibility is that lack of school-related
enrichment could result in low D2/D3 receptor availability, but this is not known. That only a
subset of participants completed a measure of IQ is also a notable limitation, because it would
have helped to indicate whether the relationship found with WCST non-perseverative errors is
specific to the cognitive domains involved, or whether this finding might be better character-
ized as being related to general cognition. Future studies will help to determine the extent to
which the relationship depends on educational attainment and IQ.
Evidence from previous PET studies indicates that the link between WCST performance
and D2/D3 receptor availability in healthy adults is not limited to the striatum. Two of these
studies showed that total perseverative errors were correlated negatively with D2/D3 receptor
availability in the hippocampus [68, 69]; and another, which surveyed several extrastriatal
regions found positive correlations between perseverative as well as non-perseverative errors
and D2/D3 receptor availability in the right anterior cingulate cortex only [70]. Broadly in line
with the former studies, we detected a modest negative association between perseverative error
rate and D2/D3 receptor availability in the hippocampi of control subjects (r = -0.327,
p = 0.186); but in contrast with the latter study, we saw no evidence of a positive association
between D2/D3 receptor availability in the anterior cingulate cortex and the rate of either per-
severative (r = -0.185, p = 0.462) or non-perseverative errors (r = -0.174, p = 0.490). In fact,
exploratory correlational analyses did not return a p-value less than 0.05 with respect to the
relationships between either error measure and D2/D3 receptor availability in any of the corti-
cal or extrastriatal subcortical regions tested (S4 Table); although they revealed some evidence
of potential negative relationships between non-perseverative error rate and D2/D3 receptor
availability in the globus pallidus and thalamus among controls. The suggestion from the
exploratory correlation analyses that the relationship between non-perseverative error rate and
D2/D3 receptor availability is primarily restricted to the striatum is also noteworthy because it
contrasts with evidence that temporal discounting of rewards (which also depends on executive
functions) is associated with D2/D3 receptor availability in a number of extrastriatal regions in
addition to the striatum [31].
In summary, we found that MA users displayed significantly lower striatal D2/D3 receptor
availability on average than controls after controlling for age and education, but they did not
register greater proportions of perseverative or non-perseverative errors on the WCST when
controlling for education. The proportion of non-perseverative errors, but not perseverative
errors, was negatively correlated with striatal D2/D3 receptor availability among controls, but
not MA users. Taken together, these results suggest that non-D2/D3 receptor-mediated mecha-
nisms can effectively buffer some aspects of executive function from deficient striatal D2/D3
receptor-mediated neurotransmission in chronic stimulant abusers.
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